marketcaparena
Search

    GOVX

    GeoVax Labs, Inc.

    Company overview

    Market capitalization
    $2.55M
    Employees
    19
    Latest publication
    2026-09-29
    About GeoVax Labs, Inc.

    GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USDQ1 20242024-03-31 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USD
    Total Revenue0USD0USD0USD0USD864,415USD0USD0USD0USD
    Research Development3,110,508USD3,903,463USD2,994,429USD5,043,504USD7,608,122USD4,425,728USD6,947,979USD4,719,728USD
    General And Administrative Expenses1,331,564USD———————
    Total Operating Expenses4,442,072USD1,369,418USD4,441,756USD1,329,711USD9,187,176USD5,863,505USD1,651,775USD1,459,093USD
    Operating Income-4,442,072USD-5,272,881USD-4,441,756USD-6,373,215USD-8,344,402USD-5,883,080USD-8,599,754USD-6,178,821USD
    Interest Income15,494USD10,960USD23,333USD54,301USD81,748USD32,949USD190,936USD251,201USD
    Net Income-4,426,578USD-5,261,921USD-4,418,423USD-6,318,914USD-8,262,653USD-5,850,132USD-8,408,818USD-5,927,620USD
    Cost Of Revenue—3,903,463USD—5,043,504USD21,641USD19,576USD6,947,979USD4,719,728USD
    Gross Profit—-3,903,463USD—-5,043,504USD842,774USD-19,576USD-6,947,979USD-4,719,728USD
    Selling General Administrative—1,369,418USD1,447,327USD1,329,711USD1,600,695USD1,457,353USD1,651,775USD1,459,093USD
    Unclassified Operating Expenses—-3,903,463USD—-5,043,504USD——-6,947,979USD-4,719,728USD
    Net Interest Income—10,960USD23,333USD54,301USD81,748USD32,949USD190,936USD251,201USD
    Income Before Tax—-5,261,921USD-4,418,423USD-6,318,914USD-8,262,653USD-5,850,132USD-8,408,818USD-5,927,620USD
    Net Income From Continuing Ops—-5,261,921USD-4,418,423USD-6,318,914USD-8,262,654USD-5,850,132USD-8,408,818USD-5,927,620USD
    Ebit—-5,261,921USD—-6,318,914USD-8,262,654USD-5,850,132USD-8,408,818USD-5,927,620USD
    Ebitda—-5,249,845USD—-6,302,112USD-8,241,013USD-5,830,556USD-8,391,499USD-5,910,302USD
    Depreciation And Amortization—12,076USD—16,802USD21,641USD19,576USD17,319USD17,318USD
    Reconciled Depreciation—12,076USD18,230USD16,802USD21,641USD19,576USD17,319USD17,318USD
    Total Other Income Expense Net—10,960USD—54,301USD81,748USD32,949USD190,936USD251,201USD
    Interest Expense——0USD0USD0USD—0USD0USD
    Selling And Marketing Expenses—————19,576USD——
    Income Tax Expense—————4USD56,905USD-104,767USD
    Net Income Applicable To Common Shares———————-5,927,620USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue0USD81,000USD385,000USD1,823,000USD1,175,896USD963,000USD1,075,270USD828,918USD
    Cost Of Revenue20,720,766USD56,284USD15,554,171USD2,444,459USD1,910,715USD1,878,652USD2,017,350USD1,970,859USD
    Gross Profit-20,720,766USD81,000USD385,000USD1,823,000USD1,175,896USD-915,652USD-942,080USD-1,141,941USD
    Research Development20,720,766USD9,123,000USD15,554,000USD2,444,000USD1,910,715USD1,879,000USD2,017,350USD1,970,859USD
    Selling General Administrative6,022,173USD4,987,000USD3,577,000USD2,196,000USD1,637,674USD1,647,000USD1,232,368USD2,131,426USD
    Unclassified Operating Expenses-20,720,766USD———————
    Total Operating Expenses6,022,173USD14,110,000USD19,131,000USD4,640,000USD3,548,389USD3,526,000USD3,249,718USD4,102,285USD
    Operating Income-26,742,939USD-14,029,000USD-18,746,000USD-2,817,000USD-2,372,493USD-2,563,000USD-2,174,448USD-3,273,367USD
    Interest Income678,527USD7,439USD4,736USD2,271USD6,359USD5,213USD4,286USD1,666USD
    Interest Expense0USD56,845USD1,286USD143,524USD4,495USD2,590USD0USD0USD
    Net Interest Income678,527USD7,439USD3,450USD-141,253USD1,864USD2,623USD4,286USD1,666USD
    Income Before Tax-25,966,762USD-14,022,000USD-18,570,000USD-2,958,000USD-2,370,629USD-2,560,000USD-2,170,162USD-3,271,701USD
    Income Tax Expense1USD-7,439USD-38,521USD-19,656USD4,495USD5,213USD0USD0USD
    Net Income-25,966,762USD-14,014,561USD-18,531,479USD-2,938,344USD-2,370,629USD-2,560,000USD-2,170,162USD-3,271,701USD
    Net Income From Continuing Ops-23,758,163USD-14,021,125USD-18,570,000USD-2,958,068USD-2,370,629USD-2,560,094USD-2,170,162USD-3,271,701USD
    Ebit-25,966,762USD-14,029,000USD-18,746,000USD-2,817,000USD-2,366,134USD-2,563,000USD-2,170,162USD-3,271,701USD
    Ebitda-25,892,593USD-13,972,716USD-18,707,479USD-2,797,344USD-2,357,784USD-2,543,199USD-2,142,135USD-3,242,921USD
    Depreciation And Amortization74,169USD56,284USD38,521USD19,656USD8,350USD19,801USD28,027USD28,780USD
    Reconciled Depreciation66,027USD56,284USD38,521USD19,656USD8,350USD19,801USD28,027USD—
    Total Other Income Expense Net776,177USD7,000USD176,000USD-141,000USD1,864USD3,000USD4,286USD1,666USD
    Net Income Applicable To Common Shares—-14,021,125USD-18,570,317USD-2,958,068USD-2,370,629USD-2,560,094USD-2,170,162USD-3,271,701USD
    Non Operating Income Net Other———2,271USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets4,642,757USD2,982,433USD6,341,868USD6,731,255USD5,350,420USD10,833,364USD8,155,867USD11,112,048USD
    Cash And Equivalents3,143,422USD———————
    Total Current Assets4,175,299USD2,431,343USD5,314,651USD6,517,248USD5,135,548USD10,612,407USD7,934,883USD10,869,423USD
    Other Current Assets1,031,877USD1,159,581USD66,843USD1,508,251USD1,508,915USD3,173,638USD1,768,533USD1,729,326USD
    Other Non Current Assets69,947USD———————
    Total Liabilities2,882,056USD———————
    Total Current Liabilities2,712,488USD2,291,560USD1,936,701USD1,824,177USD2,529,224USD2,935,334USD3,107,332USD2,608,172USD
    Other Current Liabilities724,670USD———————
    Total Stockholder Equity1,760,701USD493,770USD3,825,132USD4,907,078USD2,821,196USD7,898,030USD5,048,535USD8,503,876USD
    Total Equity Including Noncontrolling Interest1,760,701USD———————
    Property Plant Equipment Net397,511USD481,143USD940,270USD127,060USD143,862USD149,947USD149,974USD171,615USD
    Accounts Payable1,834,245USD1,430,885USD790,750USD976,411USD1,830,148USD2,403,042USD1,849,760USD2,147,952USD
    Short Term Debt153,573USD197,468USD——————
    Common Stock7,369USD2,819USD—29,705USD15,925USD13,839USD10,537USD8,609USD
    Retained Earnings-160,509,351USD-156,082,773USD-150,820,852USD-146,402,429USD-140,083,515USD-134,713,732USD-129,356,081,000,000USD-121,093,427USD
    Intangible Assets—50,000USD50,000USD50,000USD60,000USD60,000USD60,000USD60,000USD
    Total Liab—2,488,663USD2,516,736USD1,824,177USD2,529,224USD2,935,334USD3,107,332USD2,608,172USD
    Other Current Liab—663,207USD—847,766USD699,076USD532,292USD1,257,572USD460,220USD
    Capital Stock—2,819USD1,732USD29,705USD15,925USD13,839USD10,537USD8,609USD
    Cash—1,271,762USD3,085,741USD5,008,997USD3,093,862USD7,438,769USD5,506,941USD8,592,523USD
    Cash And Short Term Investments—1,271,762USD—5,008,997USD3,093,862USD7,438,769USD5,506,941USD8,592,523USD
    Net Debt—-877,191USD—-5,008,997USD-3,093,862USD-7,438,769USD-5,506,941USD-8,592,523USD
    Short Long Term Debt Total—394,571USD——————
    Property Plant Equipment Gross—896,826USD1,343,877USD938,628USD938,628USD927,910USD911,016USD911,016USD
    Common Stock Shares Outstanding—2,008,134shares1,732,147shares811,488shares614,369shares11,954,797shares10,536,875shares6,404,797shares
    Non Current Assets Total—551,090USD1,027,217USD214,006USD214,872USD220,957USD220,984USD242,625USD
    Non Current Liabilities Total—197,103USD580,035USD0USD0USD2,934USD0USD0USD
    Non Currrent Assets Other—19,947USD—86,946USD11,010USD71,010USD11,010USD71,010USD
    Net Working Capital—139,783USD3,377,950USD4,693,071USD2,606,324USD7,677,073USD4,827,551USD8,261,251USD
    Unclassified Equity—156,570,905USD154,644,252USD151,250,097USD142,872,861USD142,584,084USD129,356,086,027,461USD129,580,085USD
    Unclassified Current Assets——2,162,067USD——-1,497,545USD——
    Unclassified Current Liabilities——1,145,951USD—————
    Net Receivables————532,771USD1,497,545USD659,409USD547,574USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets6,341,868USD8,155,867USD9,283,219USD31,348,000USD11,797,000USD10,394,000USD468,880USD642,000USD
    Intangible Assets50,000USD60,000USD70,000USD80,000USD————
    Other Current Assets2,228,910USD2,427,942,000,000USD1,433,153USD1,325,998USD156,240USD168,689USD190,640USD199,080USD
    Total Liab2,516,736USD3,107,332USD3,519,881USD4,748,000USD7,435,000USD825,000USD2,043,436USD1,664,000USD
    Total Stockholder Equity3,825,132USD5,048,535USD5,763,338USD26,600,000USD4,362,000USD9,569,000USD-1,574,556USD-1,022,000USD
    Other Current Liab882,816USD1,257,572USD716,931USD3,000,212USD3,377,826USD359,281USD1,851,040USD1,238,552USD
    Common Stock1,732USD10,537USD1,977USD26,335USD6,382USD3,834USD300USD218,903USD
    Capital Stock1,732USD10,537USD1,977USD26,335USD6,382USD79,929USD1,932,733USD2,190,236USD
    Retained Earnings-150,820,852USD-129,356,081,000,000USD-104,363,785USD-78,397,023USD-64,375,898USD-45,805,581USD-42,847,513USD-40,476,884USD
    Cash3,085,741USD5,506,941USD6,452,589USD27,613,000USD11,424,000USD9,884,000USD283,341USD260,000USD
    Cash And Short Term Investments3,085,741USD5,506,941USD6,452,589USD27,613,000USD11,424,000USD9,884,000USD283,341USD260,000USD
    Total Current Assets5,314,651USD7,934,883USD7,885,742USD28,939,000USD11,629,000USD10,235,000USD447,264USD620,000USD
    Total Current Liabilities1,936,701USD3,107,332USD3,519,881USD4,747,894USD5,435,360USD810,309USD2,016,193USD1,624,831USD
    Net Debt-2,242,571USD-5,506,941USD-6,452,589USD-27,613,000USD-11,424,000USD-9,685,936USD-243,598USD40,000USD
    Short Term Debt263,135USD————183,326USD12,500USD260,420USD
    Short Long Term Debt Total843,170USD————198,064USD39,743USD300,000USD
    Accounts Payable790,750USD1,849,760USD2,802,950USD1,747,682USD2,057,534USD267,702USD152,653USD125,859USD
    Property Plant Equipment Net940,270USD149,974USD209,689USD2,409,000USD168,000USD159,000USD10,606USD22,000USD
    Property Plant Equipment Gross1,343,877USD911,016USD890,363USD841,417USD707,159USD147,741USD10,610USD11,350USD
    Common Stock Shares Outstanding958,443shares5,187,038shares1,817,282shares1,131,546shares406,622shares92,255shares0shares1shares
    Non Current Assets Total1,027,217USD220,984USD1,397,477USD2,409,000USD168,000USD159,000USD21,616USD22,000USD
    Non Current Liabilities Total580,035USD0USD0USD1,747,682USD2,000,000USD14,738USD27,243USD39,580USD
    Non Currrent Assets Other36,947USD11,010USD1,187,788USD2,174,286USD11,010USD11,010USD11,010USD11,010USD
    Net Working Capital3,377,950USD4,827,551USD4,365,861USD24,190,836USD6,193,756USD9,424,839USD-1,568,929USD-1,005,127USD
    Unclassified Equity154,642,520USD129,356,086,027,461USD110,123,169USD104,944,353USD68,725,134USD55,290,818USD39,339,924USD37,708,995USD
    Short Term Investments—5,506,935,493,059USD——————
    Net Receivables—659,409USD——49,006USD182,663USD68,603USD121,814USD
    Unclassified Current Assets—-7,934,875,724,526USD——————
    Accumulated Other Comprehensive Income——0USD0USD0USD0USD—-663,250USD
    Other Assets———2,174,286USD11,010USD11,010USD11,010USD11,010USD
    Net Tangible Assets———26,600,034USD4,361,704USD9,492,757USD-3,506,989USD-2,993,680USD
    Unclassified Non Current Assets———-4,428,572USD————
    Unclassified Non Current Liabilities———1,747,682USD-2,000,000USD———
    Other Liab————2,000,000USD———
    Inventory————-49,006USD-182,663USD—-121,814USD
    Non Current Liabilities Other————2,000,000USD———
    Short Long Term Debt—————183,326USD12,500USD260,420USD
    Long Term Debt—————14,738USD27,243USD39,580USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-5,261,921USD-4,418,420USD-6,318,914USD-5,369,783USD-5,357,651USD-8,262,654USD-5,815,468USD-5,064,042USD
    Depreciation12,076USD18,230USD16,802USD16,803USD16,921USD21,641USD30,408USD23,743USD
    Stock Based Compensation219,317USD252,124USD277,546USD292,740USD292,744USD528,643,610,700USD129,923USD101,641USD
    Other Non Cash Items252,124USD—277,546USD725,842USD-917,694USD-528,643,471,355USD129,923USD-1USD
    Change To Account Receivables126,638USD—532,771USD964,774USD-838,136USD-111,835USD-246,897USD-300,677USD
    Change In Working Capital1,492,807USD-813,707USD-187,549USD725,842USD-917,694USD348,118USD-3,642,046USD2,997,611USD
    Total Cash From Operating Activities-3,537,721USD-4,961,776USD-6,212,115USD-4,334,398USD-5,965,680USD-7,753,550USD-9,297,183USD-1,941,048USD
    Capital Expenditures-4USD0USD-5USD-10,718USD-16,894USD0USD-20,653USD-2USD
    Free Cash Flow-3,537,720USD-4,961,776USD-6,212,120USD-4,345,116USD-5,982,574USD-7,753,550USD-9,317,836USD-1,941,050USD
    Total Cashflows From Investing Activities-27,612,000,000USD—27,612USD-10,718USD-16,894USD—-20,653USD—
    Total Cash From Financing Activities1,723,742USD3,038,520USD8,127,250USD209USD7,914,402USD4,667,968USD16,348,647USD2,733,901USD
    Issuance Of Capital Stock1,718,901USD3,038,520USD7,971,250USD0USD7,914,402USD4,667,968USD15,520,877USD1,209,538USD
    Change In Cash-1,813,979USD-1,923,256USD1,915,135USD-4,344,907USD1,931,828USD-3,085,582USD7,030,811USD792,853USD
    Begin Period Cash Flow3,085,741USD5,008,997USD3,093,862USD7,438,769USD5,506,941USD8,592,523USD1,561,712USD768,859USD
    End Period Cash Flow1,271,762USD3,085,741USD5,008,997USD3,093,862USD7,438,769USD5,506,941USD8,592,523USD1,561,712USD
    Other Cashflows From Investing Activities-27,611,972,388USD——-10,718USD-16,894USD-20,655USD——
    Other Cashflows From Financing Activities1,723,742USD—8,127,250USD209USD7,914,402USD-150,000USD977,770USD2,733,901USD
    Unclassified Financing Cash Flow-1,718,901USD—-7,971,250USD—-7,914,402USD——-1,209,538USD
    Net Borrowings—0USD0USD——0USD-150,000USD—
    Investments——0USD-10,718USD-16,894USD0USD-20,653USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-21,464,771USD-24,992,296USD-25,966,762USD-14,021,125USD-18,570,317USD-2,958,068USD-2,370,629USD-2,560,094USD
    Depreciation68,756USD95,368USD74,169USD56,284USD38,521USD19,656USD8,350USD19,801USD
    Stock Based Compensation1,115,154USD528,644USD1,074,957USD902,074USD369,987USD64,463USD327,500USD469,724USD
    Other Non Cash Items1,115,154USD-25,299,497,700,477USD-1,228,013,000,000USD3,653,102USD37,769USD124,185USD327,500USD18,263USD
    Change To Account Receivables659,409USD-659,409USD—49,006USD133,657USD-114,060USD53,211USD-62,056USD
    Change In Working Capital-1,193,108USD-307,227USD-356,003USD-5,967,441USD6,927,620USD-806USD636,282USD527,543USD
    Total Cash From Operating Activities-21,473,969USD-24,675,511USD-25,173,639USD-19,030,208USD-11,196,420USD-2,750,570USD-1,398,497USD-1,543,026USD
    Capital Expenditures-27,612USD-20,653USD-48,946USD-134,258USD-47,718USD-156,791USD-7,603USD-7,606USD
    Free Cash Flow-21,501,581USD-24,696,164USD-25,222,585USD-19,164,466USD-11,244,138USD-2,907,361USD-1,406,100USD-1,543,026USD
    Total Cashflows From Investing Activities-27,612USD-20,653USD-48,946USD-134,258USD-47,718USD-156,791USD-7,606USD-7,606USD
    Net Borrowings0USD-15,000USD0USD0USD-27,864USD1,046,820USD-10,257USD300,000USD
    Total Cash From Financing Activities19,080,381USD23,750,516USD4,062,442USD35,353,328USD12,784,212USD12,507,816USD1,429,743USD1,490,000USD
    Issuance Of Capital Stock18,924,172USD21,398,383USD0USD27,727,194USD9,408,920USD11,458,496USD1,440,000USD1,190,000USD
    Change In Cash-2,421,200USD-945,648USD-21,160,143USD16,188,862USD1,540,074USD9,600,455USD23,640USD-53,026USD
    Begin Period Cash Flow5,506,941USD6,452,589USD27,612,732USD11,423,870USD9,883,796USD283,341USD259,701USD312,727USD
    End Period Cash Flow3,085,741USD5,506,941USD6,452,589USD27,612,732USD11,423,870USD9,883,796USD283,341USD259,701USD
    Other Cashflows From Investing Activities-27,611,972,388USD-20,653,000,000USD—-134,258,000,000USD————
    Other Cashflows From Financing Activities19,080,361,919,619USD2,367,133USD4,062,442USD7,626,134USD3,403,156USD302,500USD2,880,000USD1,190,000USD
    Unclassified Operating Cash Flow-1,115,154USD25,299,497,700,477USD1,228,013,000,000USD-3,653,102USD————
    Unclassified Investing Cash Flow27,611,972,388USD20,653,020,653USD—134,258,134,258USD————
    Unclassified Financing Cash Flow-19,080,361,763,410USD——27,727,194USD9,409,920USD—-2,880,000USD-1,190,000USD
    Investments—-20,653USD-29,997USD-134,258USD-47,718USD-156,791USD-7,606USD0USD
    Change To Inventory———-49,006USD-133,657USD114,060USD-53,211USD—
    Change To Liabilities———-2,687,466USD6,810,233USD137,956USD639,282USD553,119USD
    Sale Purchase Of Stock———0USD-1,000USD11,460,996USD1,440,000USD1,190,000USD
    Cash And Cash Equivalents Changes—————9,600,455USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2020Yearly · 2020-12-31ProductNIHGrants1,438,465USD0001437749-22-005677
    FY 2020Yearly · 2020-12-31ProductResearch Agreements385,193USD0001437749-22-005677
    Q4 2020Quarterly · 2020-12-31ProductNIHGrants251,621USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductResearch Agreements1USDLegacy provider
    Q3 2020Quarterly · 2020-09-30ProductLeidos Inc Research Collaborative Agreement184,128USD0001437749-21-026298
    Q3 2020Quarterly · 2020-09-30ProductNIHGrants231,330USD0001437749-21-026298
    Q2 2020Quarterly · 2020-06-30ProductLeidos Inc Research Collaborative Agreement139,109USD0001437749-21-019478
    Q2 2020Quarterly · 2020-06-30ProductNIHGrants301,493USD0001437749-21-019478
    Q1 2020Quarterly · 2020-03-31ProductLeidos Inc Research Collaborative Agreement61,956USD0001437749-21-011130
    Q1 2020Quarterly · 2020-03-31ProductNIHGrants654,021USD0001437749-21-011130
    FY 2019Yearly · 2019-12-31ProductNIHGrants983,682USD0001437749-21-006906
    FY 2019Yearly · 2019-12-31ProductResearch Agreements192,214USD0001437749-21-006906
    Q4 2019Quarterly · 2019-12-31ProductNIHGrants229,660USDLegacy provider
    Q4 2019Quarterly · 2019-12-31ProductResearch Agreements38,854USDLegacy provider
    Q3 2019Quarterly · 2019-09-30ProductNIHGrants214,765USD0001437749-20-022819
    Q3 2019Quarterly · 2019-09-30ProductResearch Agreements118,444USD0001437749-20-022819
    Q2 2019Quarterly · 2019-06-30ProductNIHGrants184,938USD0001437749-20-017250
    Q2 2019Quarterly · 2019-06-30ProductResearch Agreements25,003USD0001437749-20-017250
    Q1 2019Quarterly · 2019-03-31ProductNIHGrants354,319USD0001437749-20-009452
    Q1 2019Quarterly · 2019-03-31ProductResearch Agreements9,913USD0001437749-20-009452
    FY 2018Yearly · 2018-12-31ProductNIHGrants934,575USD0001437749-20-006029
    FY 2018Yearly · 2018-12-31ProductResearch Agreements28,628USD0001437749-20-006029
    FY 2017Yearly · 2017-12-31ProductGovernment Contract95,000USD0001437749-19-005682
    FY 2017Yearly · 2017-12-31ProductNIHGrants980,270USD0001437749-19-005682
    FY 2016Yearly · 2016-12-31ProductGovernment Contract0USD0001437749-19-005682
    FY 2016Yearly · 2016-12-31ProductNIHGrants828,918USD0001437749-19-005682

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.